🇺🇸 FDA
Patent

US 10900039

Methods for treating aging and skin disorders using nucleic acids targeting Tyr or MMP1

granted A61KA61K31/713A61P

Quick answer

US patent 10900039 (Methods for treating aging and skin disorders using nucleic acids targeting Tyr or MMP1) held by Phio Pharmaceuticals Corp. expires Mon Jan 21 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Phio Pharmaceuticals Corp.
Grant date
Tue Jan 26 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 21 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K31/713, A61P, A61P1/02, A61P15/00